CytomX Therapeutics
CTMX
CTMX
119 hedge funds and large institutions have $299M invested in CytomX Therapeutics in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.33% more ownership
Funds ownership: 78.92% → 79.25% (+0.33%)
Holders
119
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.13M | |
| 2 | +$5.99M | |
| 3 | +$4.41M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$4.01M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.41M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$12.6M | |
| 3 | -$9.23M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.58M |
| 5 |
SIM
Spark Investment Management
New York
|
-$1.11M |